Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Transdermal Patches Market, by End User
1.4.2 Europe Transdermal Patches Market, by Distribution Channel
1.4.3 Europe Transdermal Patches Market, by Adhesive Type
1.4.4 Europe Transdermal Patches Market, by Patch Type
1.4.5 Europe Transdermal Patches Market, by Application
1.4.6 Europe Transdermal Patches Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis – Global
4.1 Market Share Analysis, 2022
4.2 Porter’s Five Forces Analysis
Chapter 5. Europe Transdermal Patches Market by End User
5.1 Europe Homecare Settings Market by Country
5.2 Europe Hospitals & Clinics Market by Country
Chapter 6. Europe Transdermal Patches Market by Distribution Channel
6.1 Europe Hospital Pharmacies Market by Country
6.2 Europe Retail Pharmacies Market by Country
6.3 Europe Online Pharmacies Market by Country
Chapter 7. Europe Transdermal Patches Market by Adhesive Type
7.1 Europe Acrylic Adhesives Market by Country
7.2 Europe Silicone Adhesives Market by Country
7.3 Europe Hydrogel Adhesives Market by Country
7.4 Europe Others Market by Country
Chapter 8. Europe Transdermal Patches Market by Patch Type
8.1 Europe Drug-In-Adhesive Market by Country
8.2 Europe Matrix Patches Market by Country
8.3 Europe Reservoir Membrane Patches Market by Country
8.4 Europe Microneedle Patches Market by Country
8.5 Europe Iontophoresis Patches Market by Country
8.6 Europe Vapour Patches Market by Country
Chapter 9. Europe Transdermal Patches Market by Application
9.1 Europe Pain Management Market by Country
9.2 Europe Smoking Cessation Market by Country
9.3 Europe Hormone Replacement Therapy Market by Country
9.4 Europe Cardiovascular Disorder Market by Country
9.5 Europe Central Nervous System Disorder Market by Country
9.6 Europe Others Market by Country
Chapter 10. Europe Transdermal Patches Market by Country
10.1 Germany Transdermal Patches Market
10.1.1 Germany Transdermal Patches Market by End User
10.1.2 Germany Transdermal Patches Market by Distribution Channel
10.1.3 Germany Transdermal Patches Market by Adhesive Type
10.1.4 Germany Transdermal Patches Market by Patch Type
10.1.5 Germany Transdermal Patches Market by Application
10.2 UK Transdermal Patches Market
10.2.1 UK Transdermal Patches Market by End User
10.2.2 UK Transdermal Patches Market by Distribution Channel
10.2.3 UK Transdermal Patches Market by Adhesive Type
10.2.4 UK Transdermal Patches Market by Patch Type
10.2.5 UK Transdermal Patches Market by Application
10.3 France Transdermal Patches Market
10.3.1 France Transdermal Patches Market by End User
10.3.2 France Transdermal Patches Market by Distribution Channel
10.3.3 France Transdermal Patches Market by Adhesive Type
10.3.4 France Transdermal Patches Market by Patch Type
10.3.5 France Transdermal Patches Market by Application
10.4 Russia Transdermal Patches Market
10.4.1 Russia Transdermal Patches Market by End User
10.4.2 Russia Transdermal Patches Market by Distribution Channel
10.4.3 Russia Transdermal Patches Market by Adhesive Type
10.4.4 Russia Transdermal Patches Market by Patch Type
10.4.5 Russia Transdermal Patches Market by Application
10.5 Spain Transdermal Patches Market
10.5.1 Spain Transdermal Patches Market by End User
10.5.2 Spain Transdermal Patches Market by Distribution Channel
10.5.3 Spain Transdermal Patches Market by Adhesive Type
10.5.4 Spain Transdermal Patches Market by Patch Type
10.5.5 Spain Transdermal Patches Market by Application
10.6 Italy Transdermal Patches Market
10.6.1 Italy Transdermal Patches Market by End User
10.6.2 Italy Transdermal Patches Market by Distribution Channel
10.6.3 Italy Transdermal Patches Market by Adhesive Type
10.6.4 Italy Transdermal Patches Market by Patch Type
10.6.5 Italy Transdermal Patches Market by Application
10.7 Rest of Europe Transdermal Patches Market
10.7.1 Rest of Europe Transdermal Patches Market by End User
10.7.2 Rest of Europe Transdermal Patches Market by Distribution Channel
10.7.3 Rest of Europe Transdermal Patches Market by Adhesive Type
10.7.4 Rest of Europe Transdermal Patches Market by Patch Type
10.7.5 Rest of Europe Transdermal Patches Market by Application
Chapter 11. Company Profiles
11.1 Johnson & Johnson
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 SWOT Analysis
11.2 Viatris, Inc. (Mylan N.V.)
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.6 SWOT Analysis
11.3 Boehringer Ingelheim International GmbH
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Regional & Segmental Analysis
11.3.4 Research & Development Expenses
11.3.5 SWOT Analysis
11.4 Endo International PLC
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental Analysis
11.4.4 Research & Development Expense
11.4.5 SWOT Analysis
11.5 Bayer AG
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 SWOT Analysis
11.6 Nitto Denko Corporation
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Segmental Analysis
11.6.4 Research & Development Expense
11.6.5 SWOT Analysis
11.7 Cipla Limited
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Acquisition and Mergers:
11.7.6 SWOT Analysis
11.8 Amneal Pharmaceuticals, Inc.
11.8.1 Company Overview
11.8.2 Financial Analysis
11.8.3 Segmental Analysis
11.8.4 Research & Development Expenses
11.8.5 Recent strategies and developments:
11.8.5.1 Product Launches and Product Expansions:
11.8.6 SWOT Analysis
11.9 Novartis AG
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.9.5 SWOT Analysis
11.10. AbbVie, Inc.
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Regional Analysis
11.10.4 Research & Development Expense
11.10.5 SWOT Analysis
Unique Offerings 